>>In 2005, he founded Critical Path Institute (C-Path), an independent, non-profit organization created jointly by the U.S. Food and Drug Administration (FDA) and the University of Arizona to help implement the FDA’s Critical Path Initiative and accelerate the development of new drugs and diagnostics.
So he’s part of the system, helped create the system, that makes it a multi-year process to get a new drug FDA approved, and is very invested in that process. No wonder he doesn’t like off-label use of an existing drug the side effects of which are well-understood.